OMPI Financial Facts
Net sales: 29.15MProvision for income taxes: 1.98M
See Full Income Statement
Intangible assets, net: 3.12M
Total liabilities and stockholders' equity: 70.97M
See Full Balance Sheet
Obagi Medical Products, Inc. (OMPI) Earnings
|
Expand Research on OMPI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +20.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/14/13  |
 |
Q412 | $0.15 | $0.14 | +$0.01 | $30.3M | $30.06M |  |
 | | Details |
| 11/1/12 |
|
Q312 | $0.22 | $0.13 | +$0.09 | $29.1M | $28.87M | = | | | Details |
| 8/2/12 |
|
Q212 | $0.18 | $0.14 | +$0.04 | $30.5M | $30.39M | = | | | Details |
| 5/3/12 |
|
Q112 | $0.16 | $0.21 | -$0.05 | $30.8M | $28.14M | = | | | Details |
| 3/8/12 |
|
Q411 | $0.24 | $0.19 | +$0.05 | $30.6M | $30.64M | = | | | Details |
| 11/9/11 |
|
Q311 | $0.24 | $0.17 | +$0.07 | $28.1M | $28.16M | = | | | Details |
| 8/4/11 |
|
Q211 | $0.18 | $0.16 | +$0.02 | $28.88M | $27.49M | = | | | Details |
| 5/5/11 |
|
Q111 | $0.16 | $0.13 | +$0.03 | $28.4M | $27.11M | = | | | Details |
